GNVC on NASDAQ

GenVec

GenVec is an American pharmaceutical company based in Gaithersburg, incorporated in Delaware.¹ Its shares trade on NASDAQ under the symbol GNVC.¹

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

TickerGNVC on NASDAQ¹
Industrypharmaceutical industry¹
HeadquartersGaithersburg¹
Websitewww.genvec.com
Incorporated inDE³
Business address910 Clopper Road, Suite 220N, Gaithersburg, Md 20878³
Filer categorySmaller reporting company³

See how the biggest companies compare on our leaderboards

What it owns

What GenVec reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, before depreciation	$1.1M⁴ Dec 31, 2016	$1.1M⁴ Dec 31, 2015	+0.2%
Accumulated depreciation	$863.0K⁴ Dec 31, 2016	$773.0K⁴ Dec 31, 2015	+11.6%
Property and equipment, net	$191.0K⁴ Dec 31, 2016	$279.0K⁴ Dec 31, 2015	−31.5%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$3.7M⁴ Dec 31, 2016	$7.0M⁴ Dec 31, 2015	−47.7%

Leadership

Who has led GenVec, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

Douglas J. Swirsky2006–2013

2010201520202025

Chief executive officerDouglas J. Swirsky Sep 5, 2013 to Jun 20, 2017⁵
Chief executive officerCynthia Collins May 25, 2012 to Jan 24, 2013⁶
PresidentDouglas J. Swirsky Sep 5, 2013 to Jun 20, 2017⁵
PresidentCynthia Collins May 25, 2012 to Jan 24, 2013⁶
Chief financial officerDouglas J. Swirsky Sep 19, 2006 to Jan 24, 2013⁷

Board members and other officers (23)

Sr. Director, Corp ControllerJames Vincent Lambert Dec 9, 2014 to Jun 20, 2017⁸
VP, ResearchDouglas E. Brough Jun 28, 2011 to Jun 20, 2017⁹
VP, Legal Affairs and StrategyMichael C. Tucker Jun 28, 2011 to Jan 20, 2012¹⁰
Chief Medical OfficerThomas Andrew Davis Jan 5, 2006 to Jan 26, 2006¹¹
Senior Vice PresidentBryan T. Butman Apr 13, 2006 to Jun 20, 2017¹²
Vice PresidentNita U. Patel Apr 13, 2006 to Jan 22, 2007¹³
Vice PresidentRussell P. Wesdyk Apr 13, 2006 to Apr 13, 2006¹⁴
Senior VP, Product DevelopmentMark Owens Thornton Dec 27, 2006 to Jan 22, 2010¹⁵
Board memberMichael Richman Apr 22, 2015 to Jun 20, 2017¹⁶
Board memberQuinterol J. Mallette Nov 6, 2014 to Jun 20, 2017¹⁷
Board memberDouglas J. Swirsky Sep 5, 2013 to Jun 20, 2017⁵
Board memberStefan Loren Sep 24, 2013 to Jun 20, 2017¹⁸
Board memberCynthia Collins May 25, 2012 to Jan 24, 2013⁶
Board memberEdward M. Connor Jun 16, 2011 to Jul 13, 2012¹⁹
Board memberKevin M. Rooney Jan 18, 2008 to Jul 13, 2012²⁰
Board memberMarc R. Schneebaum Apr 20, 2007 to Jun 20, 2017²¹
Board memberFranklin Barbara Hackman Jun 26, 2006 to Jun 26, 2006²²
Board memberHarold R. Werner Jun 26, 2006 to Jun 15, 2007²³
Board memberJoshua Ruch Jun 26, 2006 to Jun 18, 2010²⁴
Board memberStelios Papadopoulos Jun 26, 2006 to Jun 26, 2006²⁵
Board memberWayne T. Hockmeyer Jun 26, 2006 to Jun 20, 2017²⁶
Board memberWillam N. Kelley Jun 26, 2006 to Jun 20, 2017²⁷
Board memberZola P. Horovitz Jun 26, 2006 to Sep 5, 2013²⁸

Timeline

Sep 5, 2013New chief executive Douglas J. Swirsky becomes CEO⁵
May 25, 2012New chief executive Cynthia Collins becomes CEO⁶

SEC filer profile

How GenVec is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARGENVEC INC²
CIK0000934473
Employer ID (EIN)23-2705690²
Filer statusSmaller reporting company²
Incorporated inDelaware²
Fiscal year endsDecember 31²
Industry code (SIC)2834 Pharmaceutical Preparations²
Business address910 Clopper Road, Suite 220N, Gaithersburg, MD 20878²
Phone2406320740²
Shares outstanding2,273,632 as of Apr 30, 2017²⁹
Public float$12.6B as of Jun 30, 2016⁴
On EDGAR sinceApr 30, 1998²
Filings702 in all: 4 (210), 8-K (160), 10-Q (49), SC 13G/A (43), 3 (25), SC 13G (23), 10-K (17), DEF 14A (16)²
All 46 form types
CT ORDER (14), 424B5 (11), CORRESP (11), SC 13D/A (11), UPLOAD (11), S-1/A (10), S-8 (10), S-3 (8), S-8 POS (7), PRE 14A (6), 10-K/A (5), 425 (5), 4/A (4), 8-K/A (4), 424B3 (3), 8-A12G (3), EFFECT (3), FWP (3), RW (3), S-4/A (3), SC 13D (3), 10-Q/A (2), DEFA14A (2), S-1 (2), S-3/A (2), 15-12G (1), 25-NSE (1), 3/A (1), 424B1 (1), 424B2 (1), 5 (1), D (1), DEFM14A (1), DEFR14A (1), NT 10-Q (1), PREM14A (1), PRER14A (1), S-4 (1)
Latest filingsAnnual report (10-K) Mar 6, 2017
Quarterly report (10-Q) May 10, 2017
Proxy statement (DEF 14A) Sep 12, 2016
Latest 8-K (8-K) Jun 16, 2017

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataGenVec on Wikidata
2
SEC EDGARGenVec filings on SEC EDGAR
3
SEC EDGARGenVec filings on SEC EDGAR
4
SEC EDGARGenVec 10-K for fiscal 2016
5
SEC EDGARDouglas J. Swirsky, Chief executive officer
6
SEC EDGARCynthia Collins, Chief executive officer
7
SEC EDGARDouglas J. Swirsky, Chief financial officer
8
SEC EDGARJames Vincent Lambert, Sr. Director, Corp Controller
9
SEC EDGARDouglas E. Brough, VP, Research
10
SEC EDGARMichael C. Tucker, VP, Legal Affairs and Strategy
11
SEC EDGARThomas Andrew Davis, Chief Medical Officer
12
SEC EDGARBryan T. Butman, Senior Vice President
13
SEC EDGARNita U. Patel, Vice President
14
SEC EDGARRussell P. Wesdyk, Vice President
15
SEC EDGARMark Owens Thornton, Senior VP, Product Development
16
SEC EDGARMichael Richman, Board member
17
SEC EDGARQuinterol J. Mallette, Board member
18
SEC EDGARStefan Loren, Board member
19
SEC EDGAREdward M. Connor, Board member
20
SEC EDGARKevin M. Rooney, Board member
21
SEC EDGARMarc R. Schneebaum, Board member
22
SEC EDGARFranklin Barbara Hackman, Board member
23
SEC EDGARHarold R. Werner, Board member
24
SEC EDGARJoshua Ruch, Board member
25
SEC EDGARStelios Papadopoulos, Board member
26
SEC EDGARWayne T. Hockmeyer, Board member
27
SEC EDGARWillam N. Kelley, Board member
28
SEC EDGARZola P. Horovitz, Board member
29
SEC EDGARGenVec 10-Q filed May 10, 2017: shares outstanding